We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-6.01%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$148M
AUM Growth
-$13.4M
(-8.3%)
Cap. Flow
+$5.17M
Cap. Flow
% of AUM
3.49%
Top 10 Holdings %
Top 10 Hldgs %
33.04%
Holding
120
New
14
Increased
23
Reduced
48
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$3.37M |
| 2 |
UPH
UpHealth, Inc.
UPH
|
+$2.17M |
| 3 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$1.55M |
| 4 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$1.35M |
| 5 |
Journey Medical
DERM
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VG
Vonage Holdings Corporation
VG
|
+$2.56M |
| 2 |
ZIXI
Zix Corporation
ZIXI
|
+$1.63M |
| 3 |
Vericel Corp
VCEL
|
+$997K |
| 4 |
CFMS
Conformis, Inc. Common Stock
CFMS
|
+$585K |
| 5 |
OptimizeRx
OPRX
|
+$557K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 58.42% |
| 2 | Technology | 16.73% |
| 3 | Industrials | 7.3% |
| 4 | Consumer Staples | 6.91% |
| 5 | Communication Services | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Vericel Corp
VCEL
$2.36B
| $2.07M | 1.4% |
52,637
-22,750
| -30% | -$997K |
|
27
Alphatec Holdings
ATEC
$1.56B
| $1.91M | 1.29% |
167,100
-4,500
| -3% | -$53.1K |
|
28
Standard BioTools
LAB
$339M
| $1.88M | 1.27% |
479,900
-40,925
| -8% | -$192K |
|
29
Target
TGT
$67.8B
| $1.8M | 1.22% |
7,779
| – | – |
|
|
ATRS
30
DELISTED
Antares Pharma, Inc.
ATRS
| $1.7M | 1.15% |
476,983
-63,800
| -12% | -$223K |
|
|
PFIE
31
DELISTED
Profire Energy, Inc
PFIE
| $1.65M | 1.11% |
1,557,945
-10,820
| -0.7% | -$12.3K |
|
32
AbbVie
ABBV
$433B
| $1.63M | 1.1% |
12,025
-288
| -2% | -$34K |
|
|
EGIO
33
DELISTED
Edgio, Inc. Common Stock
EGIO
| $1.56M | 1.05% |
+11,388
| New | +$1.35M |
|
|
SMED
34
DELISTED
Sharps Compliance Corp
SMED
| $1.56M | 1.05% |
218,455
+100,455
| +85% | +$771K |
|
35
General Mills
GIS
$19.2B
| $1.44M | 0.97% |
21,350
+13,625
| +176% | +$866K |
|
36
Elutia
ELUT
$38.3M
| $1.44M | 0.97% |
227,729
-696
| -0.3% | -$4.08K |
|
37
Castle Biosciences
CSTL
$928M
| $1.42M | 0.96% |
33,170
+20
| +0.1% | +$1.04K |
|
38
Ciena
CIEN
$55.3B
| $1.41M | 0.95% |
18,250
| – | – |
|
39
Achieve Life Sciences
ACHV
$649M
| $1.36M | 0.92% |
174,600
+5,000
| +3% | +$39.3K |
|
|
AUGX
40
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.35M | 0.91% |
+429,000
| New | +$1.55M |
|
|
AKTS
41
DELISTED
Akoustis Technologies Inc
AKTS
| $1.29M | 0.87% |
192,950
+10,750
| +6% | +$80.3K |
|
42
QuickLogic
QUIK
$238M
| $1.24M | 0.83% |
241,785
| – | – |
|
43
Advanced Micro Devices
AMD
$790B
| $1.22M | 0.82% |
8,450
| – | – |
|
44
Rockwell Medical
RMTI
$28.5M
| $1.21M | 0.82% |
26,882
+6,894
| +34% | +$369K |
|
|
BIOL
45
DELISTED
Biolase, Inc.
BIOL
| $1.19M | 0.8% |
1,219
-35
| -3% | -$44.1K |
|
|
AVGR
46
DELISTED
Avinger, Inc. Common Stock
AVGR
| $1.15M | 0.78% |
8,516
+650
| +8% | +$128K |
|
47
Gilead Sciences
GILD
$163B
| $1.15M | 0.77% |
15,767
-533
| -3% | -$36.7K |
|
48
3M
MMM
$91.4B
| $1.14M | 0.77% |
7,662
-179
| -2% | -$26.7K |
|
|
PDCO
49
DELISTED
Patterson Companies, Inc.
PDCO
| $1.11M | 0.75% |
37,950
+1,000
| +3% | +$31.3K |
|
50
Perspective Therapeutics
CATX
$343M
| $1.09M | 0.73% |
280,100
+124,800
| +80% | +$666K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Perkins Capital Management held 120 positions worth $148M, down 8.3% from $162M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Perkins Capital Management deployed $5.17M of net new capital in Q4 2021, opening 14 new positions and adding to 23 existing holdings. Its largest new stake was UpHealth, Inc.: 93,945 shares worth $2.1M.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 62% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Vericel Corp, an estimated $997K trimmed.
- Perkins Capital Management's largest Q4 2021 buy was UpHealth, Inc.: 93,945 shares worth $2.1M.
- Perkins Capital Management added most to ASPEN GROUP, INC. in Q4 2021, an estimated $3.37M increase.
- Perkins Capital Management's biggest Q4 2021 reduction was Vericel Corp, cutting an estimated $997K.
- Perkins Capital Management fully exited Vonage Holdings Corporation in Q4 2021, selling an estimated $2.56M.
- Perkins Capital Management's ten largest holdings make up 33% of its $148M portfolio in Q4 2021.
- Perkins Capital Management opened 14 new positions and closed 11 in Q4 2021.
- Perkins Capital Management's portfolio value fell 8.3% quarter-over-quarter to $148M.
Based on Perkins Capital Management's 13F filing for Q4 2021, filed 10 Feb 2022.